Neurotrophic Keratopathy Clinical Trials in Tampa, Florida
2 recruitingTampa, Florida
Showing 1–2 of 2 trials
Recruiting
Phase 4
Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency
Ocular Surface DiseaseNeurotrophic Keratopathy Stage 1
University of South Florida50 enrolled1 locationNCT07502378
Recruiting
Phase 3
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Neurotrophic Keratopathy
ReGenTree, LLC70 enrolled36 locationsNCT05555589